SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-029266
Filing Date
2018-05-16
Accepted
2018-05-16 17:03:30
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv494008_10q.htm 10-Q 547307
2 EXHIBIT 31.1 tv494008_ex31-1.htm EX-31.1 9077
3 EXHIBIT 32.1 tv494008_ex32-1.htm EX-32.1 4164
  Complete submission text file 0001144204-18-029266.txt   6917876

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20180331.xml EX-101.INS 1837346
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20180331.xsd EX-101.SCH 65105
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20180331_cal.xml EX-101.CAL 38163
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20180331_def.xml EX-101.DEF 469065
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20180331_lab.xml EX-101.LAB 439589
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20180331_pre.xml EX-101.PRE 488240
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 18840712
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1